Applied Genetic Technolo... Stock Price - AGTC

0.0187 (0.39%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Applied Genetic Technologies Corporation AGTC NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.0187 0.39% 4.8187 4.75 4.9483 4.82 4.80 10:15:49
Bid Price Ask Price Spread Spread % News
4.81 4.83 0.02 0.41% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
263 35,990 $ 4.82 $ 173,440 243,104 2.29 - 10.42
Last Trade Time Type Quantity Stock Price Currency
10:15:48 5 $ 4.83 USD

Applied Genetic Technolo... Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 124.16M 25.77M 25.52M $ 41.69M $ - -0.10 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - 0.90%

more financials information »

Applied Genetic Technolo... News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AGTC Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week4.715.354.604.95411,3270.10872.31%
1 Month3.935.353.874.53281,5080.888722.61%
3 Months4.045.352.293.82233,1240.778719.27%
6 Months2.7210.422.297.21783,4102.1077.16%
1 Year3.7310.422.296.77445,6641.0929.19%
3 Years5.1510.422.265.98233,752-0.3313-6.43%
5 Years20.0721.432.267.88198,042-15.25-75.99%

Applied Genetic Technolo... Description

Applied Genetic Technologies Corp is a clinical-stage biotechnology company that uses a proprietary gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. Its initial focus is in the field of ophthalmology, where it has active clinical trials in X-linked retinitis pigmentosa, achromatopsia (ACHM CNGB3 & ACHM CNGA3), and X-linked retinoschisis. In addition to its clinical trials, company has preclinical programs in optogenetics, adrenoleukodystrophy, which is a disease of the central nervous system, other ophthalmology and otology indications. The optogenetics program is being developed in collaboration with Bionic Sight.

Your Recent History
Applied Ge..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.